Tiumed LLC has announced the addition of Richard Nazarian, a highly experienced executive leader, to its board of managers on April 12.
“We are extremely pleased to welcome Rich to our board of managers,” said Scott Latterell, Tiumed’s founder and CEO. “His extensive and varied background from 25 plus years as the founding CEO of Minnetronix Medical, a design, development and manufacturing partner to leading device companies around the world, will provide invaluable guidance as Tiumed enters its next phase.”
Mr. Nazarian has over three decades of med-tech industry experience. From 1996 to 2020 Rich led Minnetronix’s growth to over $100M in annual revenues and built a workforce of over 300 employees that included 125+ scientists and engineers. Involved in every aspect of corporate operations and governance, Rich led the company’s evolution from founder-driven to scalable, forward-looking, and enduring.
Headquartered in Minneapolis, MN and a member of Medical Alley, Tiumed is developing a next-generation bipolar plasma platform to address the unmet needs of BPH surgery stakeholders by delivering higher efficiency and precision, effectiveness and patient satisfaction, at lower costs.
In the US alone, each year 400K men still rely on surgical treatment for their BPH (enlarged prostate), vs. pharmaceutical or office-based therapies, for adequate symptom relief. With no innovation in almost two decades, the results and costs of surgical technology currently used has left physicians and their patients dissatisfied, and impeded access to better treatment. Tiumed’s customer-focused approach aims to provide more efficient and effective procedures while utilizing existing skills and tools, leading to improved outcomes with lower costs and increased access to better healthcare.